Most Recent Articles about MRK
What's in the Cards for AstraZeneca (AZN) in Q3 Earnings? http://www.zacks.com/stock/news/575739/whats-in-the-cards-for-astrazeneca-azn-in-q3-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-575739 Oct 21, 2019 - AstraZeneca's (AZN) third-quarter result is expected to reflect the impact of new drug sales.
What's in Store for Healthcare ETFs in Q3 Earnings? http://www.zacks.com/stock/news/575582/whats-in-store-for-healthcare-etfs-in-q3-earnings?cid=CS-ZC-FT-etf_news_and_commentary-575582 Oct 21, 2019 - With earnings surprise in the cards, the healthcare sector is expected to witness modest earnings growth of 0.3% in the third quarter, suggesting some room for potential upside for healthcare ETFs.
Factors Setting the Tone for Novartis' (NVS) Q3 Earnings http://www.zacks.com/stock/news/571262/factors-setting-the-tone-for-novartis-nvs-q3-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-571262 Oct 18, 2019 - Investors will focus on regular top and bottom-line numbers along with pipeline updates, when Novartis (NVS) reports third-quarter 2019 results.

Related Companies

Name Exchange Price Mkt Cap
NVS Novartis AG NYSE $85.13 $197.65B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
PFE Pfizer, Inc. NYSE $43.01 $252.13B
ABT Abbott Laboratories NYSE $67.67 $118.71B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals